REGISTERED
on 04 Jul 2023
Last Applicant/ Owned by
Gangnam-gu Seoul
KR
Serial Number
79342263 filed on 17th Mar 2022
Registration Number
7095522 registered on 04th Jul 2023
Correspondent Address
Jong Park
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
ILLIMIS
Pharmaceutical product development; pharmaceutical research and development of medicines in the field of age-related diseases/disorders and degenerative diseases; pharmaceutical research and development of medicines in the field of chronic malady/disease and dysfunction; scientific research for medical purposes in the field of gene therapy; medical scientific research in the field of brain disease Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical product development; pharmaceutical research and development of medicines in the field of age-related diseases/disorders and degenerative diseases; pharmaceutical research and development of medicines in the field of chronic malady/disease and dysfunction; scientific research for medical purposes in the field of gene therapy; medical scientific research in the field of brain disease; medical scientific research in the field of neurological diseases; biotechnology research and scientific and pharmaceutical research in the antibody field; biological research; scientific research in the field of cancer disease; remote monitoring and quality control inspection for others of active substances in the pharmaceutical research field and scientific analysis of active substances in the pharmaceutical research field; research for quality inspection related to human hygiene management for medical research purposes; scientific and medical research of autoimmune disease; development of pharmaceutical preparations for cell therapy; stem cell collection for medical research; cell processing and culture for medical research; pharmaceutical research and development of medicines in the field of inflammatory disease; pharmaceutical research and development of medicines in the field of eye disease; pharmaceutical research and development of medicines in the field of amyloidosis; consultancy pertaining to pharmacology relating to pharmaceutical quality control; providing information on the research of medical products relating to pharmaceutical quality control
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for activating cellular function; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for respiratory organs; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of inflammatory diseases; ophthalmic preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of degenerative brain disease; pharmaceutical preparations for the treatment of brain dysfunction; pharmaceutical preparations for the treatment of stroke; pharmaceutical preparations for the treatment of cerebrovascular disease; pharmaceutical preparations for the treatment of dementia; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
Mark Details
Serial Number
No 79342263
Mark Type
No Service Mark
Attorney Docket Number
No T49523JD06
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 31st Oct 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 06th Oct 2023 | FINAL DISPOSITION PROCESSED |
| 06th Oct 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| 04th Oct 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 04th Jul 2023 | REGISTERED-PRINCIPAL REGISTER |
| 04th Jul 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 10th May 2023 | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| 25th Apr 2023 | NOTIFICATION PROCESSED BY IB |
| 18th Apr 2023 | PUBLISHED FOR OPPOSITION |
| 18th Apr 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |